详情页 - 首都医科大学附属北京同仁医院知识库

当前位置：首页 > 详情页

Safety and efficacy of transcatheter arterial embolization for management of refractory hematuria of prostatic origin

文献详情

资源类型：

Pubmed体系：

作者：

机构： [1]Department of Radiology, Beijing Tongren Hospital, Capital Medical University, Beijing, 100730, China. [2]Interventional Department, Huabei Petroleum General Hospital, Renqiu, 062552, China. [3]Departments of Interventional Radiology, Chinese PLA General Hospital, Beijing, 100853, PR China. [4]Shengli Clinical Medical College of Fujian Medical University, Fuzhou, 350122, PR China. [5]Department of Interventional Radiology, Fujian Provincial Hospital, Fuzhou, 350001, PR China.

出处：

DOI：

ISSN：

关键词： Transcatheter arterial embolization Hematuria Benign prostatic hyperplasia

摘要：

To estimate the safety and efficacy of transcatheter arterial embolization (TAE) in the treatment of refractory hematuria of prostatic origin (RHPO).This retrospective study included 23 patients who underwent TAE for RHPO between May 2013 and August 2021. Technical and clinical success rates were calculated, and arteriogram findings and complications were detected.Embolization was performed 24 times in 23 patients. Technical success was achieved in 24/24 (100%) embolization procedures. Contrast agent extravasation was detected during 2 of the 24 angiographic procedures. Bilateral embolization was performed in 23 (95.8%) of the 24 procedures. The clinical success rate was 21/23 (91.3%), and hematuria stopped 1-4 days after TAE. No serious complications were observed.TAE is a safe and effective minimally invasive technique for treating patients with RHPO.© 2022 Shanghai Journal of Interventional Radiology Press. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.

基金：

语种：

PubmedID：

第一作者：

第一作者机构： [1]Department of Radiology, Beijing Tongren Hospital, Capital Medical University, Beijing, 100730, China.

共同第一作者：

通讯作者：

通讯机构： [3]Departments of Interventional Radiology, Chinese PLA General Hospital, Beijing, 100853, PR China. [4]Shengli Clinical Medical College of Fujian Medical University, Fuzhou, 350122, PR China. [5]Department of Interventional Radiology, Fujian Provincial Hospital, Fuzhou, 350001, PR China. [*1]Shengli Clinical Medical College of Fujian Medical University, Fuzhou 350122, PR China Department of Interventional Radiology, Fujian Provincial Hospital, Fuzhou, 350001, PR China [*2]Department of Interventional Radiology, Chinese PLA General Hospital, Beijing 100853, PR China

推荐引用方式(GB/T 7714)：

APA：

MLA：

相关文献

[1]Safety and efficacy of transcatheter arterial embolization for management of refractory hematuria of prostatic origin [2]Development and evaluation of polyacrylamide microspheres loaded with phloretin and tantalum for transcatheter arterial embolization [3]经尿道激光治疗前列腺增生症118例报告 [4]Establishment of hormone-induced canine benign prostatic hyperplasia model: A prospective, controlled study [5]Transcatheter arterial embolization with N-butyl cyanoacrylate for postoperative hemorrhage treatment following pancreatoduodenectomy [6]A Modified Technique of Thulium Laser Enucleation for Benign Prostatic Hyperplasia With Non-morcellator Approach [7]Identification of key genes in benign prostatic hyperplasia using bioinformatics analysis [8]经尿道前列腺电切术后患者排尿顺畅的措施和临床分析 [9]膀胱内前列腺突出程度与前列腺增生进展关系一例 [10]The Efficacy and Safety of Silodosin Singly or Combined With Ningmitai Capsules in the Treatment of Benign Prostatic Hyperplasia (NQTIPS)